These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

120 related items for PubMed ID: 1611298

  • 1. In vivo regulation of matrix vesicle concentration and enzyme activity during primary bone formation.
    Schwartz Z, Swain L, Sela J, Gross U, Amir D, Kohavi D, Muller-Mai C, Boyan B.
    Bone Miner; 1992 May; 17(2):134-8. PubMed ID: 1611298
    [Abstract] [Full Text] [Related]

  • 2. Modulation of matrix vesicle enzyme activity and phosphatidylserine content by ceramic implant materials during endosteal bone healing.
    Schwartz Z, Swain LD, Marshall T, Sela J, Gross U, Amir D, Muller-Mai C, Boyan BD.
    Calcif Tissue Int; 1992 Dec; 51(6):429-37. PubMed ID: 1451010
    [Abstract] [Full Text] [Related]

  • 3. Markers of primary mineralization are correlated with bone-bonding ability of titanium or stainless steel in vivo.
    Braun G, Kohavi D, Amir D, Luna M, Caloss R, Sela J, Dean DD, Boyan BD, Schwartz Z.
    Clin Oral Implants Res; 1995 Mar; 6(1):1-13. PubMed ID: 7669863
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Response of bone and cartilage cells to biomaterials in vivo and in vitro.
    Boyan BD, Schwartz Z, Hambleton JC.
    J Oral Implantol; 1993 Mar; 19(2):116-22; discussion 136-7. PubMed ID: 8246298
    [Abstract] [Full Text] [Related]

  • 9. Primary mineralization at the surfaces of implants.
    Sela J, Gross UM, Kohavi D, Shani J, Dean DD, Boyan BD, Schwartz Z.
    Crit Rev Oral Biol Med; 2000 Mar; 11(4):423-36. PubMed ID: 11132764
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Stimulation of matrix vesicle enzyme activity in osteoblast-like cells by 1,25(OH)2D3 and transforming growth factor beta (TGF beta).
    Bonewald LF, Schwartz Z, Swain LD, Boyan BD.
    Bone Miner; 1992 May; 17(2):139-44. PubMed ID: 1611299
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Osteosarcoma hybrids can preferentially target alkaline phosphatase activity to matrix vesicles: evidence for independent membrane biogenesis.
    Leach RJ, Schwartz Z, Johnson-Pais TL, Dean DD, Luna M, Boyan BD.
    J Bone Miner Res; 1995 Nov; 10(11):1614-24. PubMed ID: 8592937
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Alpha 2-HS-glycoprotein: expression in chondrocytes and augmentation of alkaline phosphatase and phospholipase A2 activity.
    Yang F, Schwartz Z, Swain LD, Lee CC, Bowman BH, Boyan BD.
    Bone; 1991 Nov; 12(1):7-15. PubMed ID: 2054237
    [Abstract] [Full Text] [Related]

  • 18. Stimulation of plasma membrane and matrix vesicle enzyme activity by transforming growth factor-beta in osteosarcoma cell cultures.
    Bonewald LF, Schwartz Z, Swain LD, Ramirez V, Poser J, Boyan BD.
    J Cell Physiol; 1990 Nov; 145(2):200-6. PubMed ID: 2246323
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.